Element Raises $276M in Series C Financing for DNA Sequencing Platform

Element Raises $276M in Series C Financing for DNA Sequencing Platform

Element Biosciences has completed a $276 million Series C financing whose proceeds are intended to fund the launch of the company’s next-generation DNA sequencing platform as well as scale its commercial operation.

Read the full article at: www.genengnews.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *